How We Source Information

Ivermectin is a subject where bad information spreads fast. This page explains which sources we use, what each one is good for, and what we leave out.

Sources we rely on

• U.S. Food and Drug Administration (FDA) — the authority for what is approved in the United States, for which conditions, and in what form. We use FDA for approval status, approved labeling, and safety communications, including its consumer guidance on ivermectin products intended for animals.
• State legislatures and state boards of pharmacy — the authority for state-level rules on prescribing and dispensing, including the handful of states that have passed laws affecting ivermectin access. Statutes and board rules differ by state and change between legislative sessions, so we cite the state body directly rather than news coverage of it.
• National Institutes of Health (NIH) and PubMed — for published research and systematic reviews. PubMed is our index for locating primary studies; we read the study, not the abstract summary alone.
• Centers for Disease Control and Prevention (CDC) — for public health guidance, parasitic disease background, and its Health Alert Network advisories.
• Manufacturer prescribing information — the labeling issued with the product is the reference for dosing, contraindications, drug interactions, and warnings. Where we state a dose or a contraindication, it comes from the label, not from a secondary article.
• GoodRx — used only as a signal for retail cash pricing ranges at U.S. pharmacies. We treat this as an estimate, not a quote.

How we handle time-sensitive facts

Prices, state laws, approval status, and public health guidance all change. We treat these as dated facts, not permanent ones.

• Any price, legal status, or guidance statement carries the month and year it was checked.
• Pages covering state law or pricing are re-checked against the original source on a scheduled basis and after any development we become aware of. The "last reviewed" date on the article reflects the most recent check, not the original publication date.
• When a fact changes, we update the sentence and the date rather than adding a note at the bottom. Substantive corrections are logged on the article.

Preprints and weak studies

Preprints have not been peer reviewed. We may mention one when it is being widely discussed, but we label it as a preprint in the same sentence and say so plainly. We do not use a preprint as the sole support for a claim about safety or effectiveness.

We give more weight to randomized controlled trials and systematic reviews than to observational studies, case series, or in vitro work. Where a study has been retracted or has documented data integrity problems, we say so if we reference it at all. Where the evidence is contested, we describe the disagreement instead of picking a side and presenting it as settled.

What we exclude

• Online sellers, pharmacy storefronts, and telehealth marketing pages.
• Affiliate content and sponsored reviews.
• Forums, comment threads, and social media posts.
• Personal testimonials presented as evidence of effectiveness.
• Secondary blogs that do not cite a primary source.

Sourcing on each article

Every article carries its own source list naming the specific organizations and documents used for that page. If a claim on this site is not traceable to a source in that list, treat it as unsupported and tell us.

How articles are produced

Articles on this site are drafted with AI assistance and then checked by a human editor against the primary sources before publication. The editor verifies quoted figures, dosing statements, legal claims, and dates. This site does not employ clinicians and is not affiliated with any government agency. Nothing here is medical advice.

To report an error or question a source, contact info@ivermectinreport.com. Publisher: IvermectinReport.com, W 10th St NE, Rome, GA 30165.